Table:
begin	end	state
1	20	cytoplasmic
21	38	transmembrane
39	57	non-cytoplasmic
58	77	transmembrane
78	90	cytoplasmic
91	109	transmembrane
110	115	non-cytoplasmic
116	138	transmembrane
139	148	cytoplasmic
149	171	transmembrane
172	182	non-cytoplasmic
183	203	transmembrane
204	250	cytoplasmic
251	272	transmembrane
273	283	non-cytoplasmic
284	304	transmembrane
305	315	cytoplasmic
316	336	transmembrane
337	341	non-cytoplasmic
342	362	transmembrane
363	372	cytoplasmic
373	394	transmembrane
395	405	non-cytoplasmic
406	426	transmembrane
427	447	cytoplasmic

Input:
>BPHYT_RS04765 FitnessBrowser__BFirm:BPHYT_RS04765
MTTQSAGPAGNALHRIATHKAMLRLIPLMCVIYFMSYLDRTNVSLAKARLATDLGISAAA
YGLGAGIFFIGYALLEVPSNLVAHRVGPRRWIARIAITWGALSASMMFVQGEWSFYAIRV
LLGIAEAGLFPALMYMVTMWFAPQDRSVAVGWIYTAPALALVIGNPLGGAFMQMDGLGGL
HGWQWLFLLEGLPTIFVGVLLWFKLPEKPSDARWLSADEARALEARAVPDAAHPGMFSQD
WVAALKRPATVLIGLIYFLNQVAFVGLVFFTPAMIQQMHVKSPLMIGVLSSSVGIGFLLG
VLVLPRIHRRVTNDCLYLGVLTLGLVTSAILFMSTSVLSTQLLLFVATAFFAGGVLPLYW
AIAMKRLHGIQAAAGLAFINTIGLIGGFVGPYLFGLAESASGHSASGFSVVVGASVLGLV
LVPLLAKAIQSEGRAASLAEPLLNTES

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server